Ablynx: Another positive development for Ablynx as BI enters phase I in Alzheimer’s disease

CORPORATE, Fair Value EUR11 (+49%)

News published on October Tuesday 29, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities